Literature DB >> 19495968

Rottlerin inhibits (Na+, K+)-ATPase activity in brain tissue and alters D-aspartate dependent redistribution of glutamate transporter GLAST in cultured astrocytes.

Khoa T D Nguyen1, Jae-Won Shin, Caroline Rae, Ellas K Nanitsos, Gabriela B Acosta, David V Pow, Vlado Buljan, Maxwell R Bennett, Paul L Else, Vladimir J Balcar.   

Abstract

The naturally occurring toxin rottlerin has been used by other laboratories as a specific inhibitor of protein kinase C-delta (PKC-delta) to obtain evidence that the activity-dependent distribution of glutamate transporter GLAST is regulated by PKC-delta mediated phosphorylation. Using immunofluorescence labelling for GLAST and deconvolution microscopy we have observed that D-aspartate-induced redistribution of GLAST towards the plasma membranes of cultured astrocytes was abolished by rottlerin. In brain tissue in vitro, rottlerin reduced apparent activity of (Na+, K+)-dependent ATPase (Na+, K+-ATPase) and increased oxygen consumption in accordance with its known activity as an uncoupler of oxidative phosphorylation ("metabolic poison"). Rottlerin also inhibited Na+, K+-ATPase in cultured astrocytes. As the glutamate transport critically depends on energy metabolism and on the activity of Na+, K+-ATPase in particular, we suggest that the metabolic toxicity of rottlerin and/or the decreased activity of the Na+, K+-ATPase could explain both the glutamate transport inhibition and altered GLAST distribution caused by rottlerin even without any involvement of PKC-delta-catalysed phosphorylation in the process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495968     DOI: 10.1007/s11064-009-9996-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts.

Authors:  B Cooper; M Chebib; J Shen; N J King; I G Darvey; P W Kuchel; J D Rothstein; V J Balcar
Journal:  Arch Biochem Biophys       Date:  1998-05-15       Impact factor: 4.013

Review 2.  Molecular pharmacology of the Na+-dependent transport of acidic amino acids in the mammalian central nervous system.

Authors:  Vladimir Josef Balcar
Journal:  Biol Pharm Bull       Date:  2002-03       Impact factor: 2.233

Review 3.  A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system.

Authors:  R J Bridges; M P Kavanaugh; A R Chamberlin
Journal:  Curr Pharm Des       Date:  1999-05       Impact factor: 3.116

4.  Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices.

Authors:  C Rae; M L Lawrance; L S Dias; T Provis; W A Bubb; V J Balcar
Journal:  Brain Res Bull       Date:  2000-11-01       Impact factor: 4.077

Review 5.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

6.  Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.

Authors:  M Danilenko; X Wang; G P Studzinski
Journal:  J Natl Cancer Inst       Date:  2001-08-15       Impact factor: 13.506

7.  Relationship between body size, Na+-K+-ATPase activity, and membrane lipid composition in mammal and bird kidney.

Authors:  Nigel Turner; Kurt L Haga; A J Hulbert; Paul L Else
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09-30       Impact factor: 3.619

8.  Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex.

Authors:  Brigitte Voutsinos-Porche; Gilles Bonvento; Kohichi Tanaka; Pascal Steiner; Egbert Welker; Jean-Yves Chatton; Pierre J Magistretti; Luc Pellerin
Journal:  Neuron       Date:  2003-01-23       Impact factor: 17.173

9.  Inhibition of calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity by dimethyl sulfoxide.

Authors:  E J McConnell; M J Wagoner; C E Keenan; B U Raess
Journal:  Biochem Pharmacol       Date:  1999-01-01       Impact factor: 5.858

10.  Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ.

Authors:  Natalie D Bull; Nigel L Barnett
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

View more
  4 in total

Review 1.  GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1.

Authors:  Omar Šerý; Nilufa Sultana; Mohammed Abul Kashem; David V Pow; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2015-05-14       Impact factor: 3.996

Review 2.  Glutamate Transporters/Na(+), K(+)-ATPase Involving in the Neuroprotective Effect as a Potential Regulatory Target of Glutamate Uptake.

Authors:  Li-Nan Zhang; Yong-Jun Sun; Li-Xue Wang; Zi-Bin Gao
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590

3.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

4.  Cardiac glycosides ouabain and digoxin interfere with the regulation of glutamate transporter GLAST in astrocytes cultured from neonatal rat brain.

Authors:  Khoa T D Nguyen; Vlado Buljan; Paul L Else; David V Pow; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2010-10-02       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.